AI assistant
Sending…
Luye Pharma Group Limited — Earnings Release 2004
Jul 23, 2004
50431_rns_2004-07-23_56a2e778-2a1b-40fb-9c47-6cd4302ef7e4.htm
Earnings Release
Open in viewerOpens in your device viewer
Listed Company Information
| Listed Company Information |
| TAKSON HOLDINGS<00918> - Results Announcement Takson Holdings Limited announced on 23/07/2004: (stock code: 00918 ) Year end date: 31/03/2004 Currency: HKD Auditors' Report: Unqualified (Audited ) (Audited ) Last Current Corresponding Period Period from 01/04/2003 from 01/04/2002 to 31/03/2004 to 31/03/2003 Note ('000 ) ('000 ) Turnover : 208,185 258,701 Profit/(Loss) from Operations : (15,270) 3,741 Finance cost : (2,461) (2,661) Share of Profit/(Loss) of Associates : N/A N/A Share of Profit/(Loss) of Jointly Controlled Entities : N/A N/A Profit/(Loss) after Tax & MI : (17,472) 1,662 % Change over Last Period : N/A % EPS/(LPS)-Basic (in dollars) : (0.045) 0.004 -Diluted (in dollars) : N/A N/A Extraordinary (ETD) Gain/(Loss) : N/A N/A Profit/(Loss) after ETD Items : (17,472) 1,662 Final Dividend : NIL NIL per Share (Specify if with other : N/A N/A options) B/C Dates for Final Dividend : N/A Payable Date : N/A B/C Dates for (-) General Meeting : N/A Other Distribution for : N/A Current Period B/C Dates for Other Distribution : N/A Remarks: Notes: (1) (Loss)/ earnings per share The calculation of basic (loss)/ earnings per share is based on the Group's loss attributable to shareholders of approximately HK$17,472,000 (2003: profit of approximately HK$1,662,000). The basic (loss)/ earnings per share is based on the weighted average number of 389,500,000 (2003: 389,500,000) ordinary shares in issue during the year. No diluted (loss)/ earnings per share is presented as there are no dilutive potential ordinary shares for the years ended 31st March, 2004 and 2003. |
More from Luye Pharma Group Limited
Proxy Solicitation & Information Statement
2026
May 29
Proxy Solicitation & Information Statement
2026
May 29
Proxy Solicitation & Information Statement
2026
May 29
Regulatory Filings
2026
May 7
Environmental & Social Information
2026
Apr 29
Regulatory Filings
2026
Apr 20
Regulatory Filings
2026
Apr 15
Regulatory Filings
2026
Apr 8
Regulatory Filings
2026
Apr 8
Earnings Release
2026
Mar 31